Goldman Sachs analyst Georgina Fraser CFA maintained a Hold rating on Evonik (0QDS – Research Report) today and set a price target of €22.70.

German chemicals group Evonik Industries on Wednesday forecast 2025 core earnings broadly in line with last year's figure and ...

Evonik sees stable 2025 core earnings, no impact from US tariffs Germany's Evonik Industries does not expect U.S. tariffs to impact its business due to local production, it said after forecasting ...

Evonik to reinforce its commitment to addressing the global food challenge through innovative animal nutrition solutions ...

XTRA:EVK Earnings and Revenue History March 12th 2025 How Do Unusual Items Influence Profit? To properly understand Evonik Industries' profit results, we need to consider the €2 ...

Shares in Evonik jumped on Wednesday after the German specialty-chemicals company posted stronger figures on year and an in-line guidance for 2025. In morning trading, shares rose 8.8% at 20.40 euros.

Goldman Sachs analyst Georgina Fraser CFA maintained a Hold rating on Evonik (0QDS – Research Report) today and set a price target of €20.00.

Investing.com-- Evonik Industries (ETR: EVKn) saw its shares surge over 10% on Wednesday after posting a solid outlook for ...

We at Evonik here pretty well placed in Germany ... what we do have in mind about the future structure and how the company and our investors, our investors have brilliant chances to benefit ...

(RTTNews) - Evonik Industries (EVK.DE ... For fiscal 2025, the company expects: sales in between 15 billion euros and 17 billion euros, and adjusted net financial result around prior-year level.

Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...